The Prolia is for use in postmenopausal women with osteoporosis at a high risk of fractures. Approximately half of women older than 50 will have an osteoporosis-related fracture in their lifetime, according to an HHS study.
The financial terms of the deal were not disclosed.
More Articles on Devices:
8 Recent Leadership & Executive Moves at Spine, Orthopedic Device Companies
FDA Grants Approval to OsteoSelect Putty for Spinal Fusions
Renaissance Spine Guidance Brings 99% Accuracy to 118 Minimally Invasive Procedures in Germany
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.